Next report date
Report period
H1 2024
EPS estimate
—
Revenue estimate
—
−0.02HKD
−24.42 MHKD
249.01 MHKD
525.60 M
About LEPU BIOPHARMA CO LTD
Sector
CEO
Ziye Sui
Headquarters
Shanghai
Website
Employees (FY)
429
Founded
2018
ISIN
CNE100004SM4
FIGI
BBG0158783P1
Lepu Biopharma Co., Ltd. is an innovation-driven biopharmaceutical company, which focuses on oncology therapeutics and endeavor to continuously develop a market differentiating pipeline by combining in-house research and development and strategic collaborations, strengthen in-house manufacturing and commercialize its pipeline products in China through dedicated sales and marketing forces and internationally via partnerships. The company was founded by Zhong Jie Pu on January 19, 2018 and is headquartered in Shanghai, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 2157 is 5.51 HKD — it has decreased by 5.00% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange LEPU BIOPHARMA CO LTD stocks are traded under the ticker 2157.
LEPU BIOPHARMA CO LTD is going to release the next earnings report on Aug 23, 2024. Keep track of upcoming events with our Earnings Calendar.
2157 stock is 18.18% volatile and has beta coefficient of 1.78. Check out the list of the most volatile stocks — is LEPU BIOPHARMA CO LTD there?
Yes, you can track LEPU BIOPHARMA CO LTD financials in yearly and quarterly reports right on TradingView.
2157 stock has risen by 25.80% compared to the previous week, the month change is a 74.37% rise, over the last year LEPU BIOPHARMA CO LTD has showed a 3.18% increase.
2157 net income for the last quarter is 129.43 M HKD, while the quarter before that showed −160.49 M HKD of net income which accounts for 180.65% change. Track more LEPU BIOPHARMA CO LTD financial stats to get the full picture.
Today LEPU BIOPHARMA CO LTD has the market capitalization of 9.62 B, it has increased by 2.34% over the last week.
No, 2157 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 2157 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LEPU BIOPHARMA CO LTD stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 30, 2024, the company has 429.00 employees. See our rating of the largest employees — is LEPU BIOPHARMA CO LTD on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LEPU BIOPHARMA CO LTD technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LEPU BIOPHARMA CO LTD stock shows the strong buy signal. See more of LEPU BIOPHARMA CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on LEPU BIOPHARMA CO LTD future price: according to them, 2157 price has a max estimate of 3.70 HKD and a min estimate of 3.70 HKD. Read a more detailed LEPU BIOPHARMA CO LTD forecast: see what analysts think of LEPU BIOPHARMA CO LTD and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LEPU BIOPHARMA CO LTD EBITDA is −316.04 M HKD, and current EBITDA margin is −128.04%. See more stats in LEPU BIOPHARMA CO LTD financial statements.